Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)

FitzGerald JD, Barrios C, Liu T, Rosenthal A, McCarthy GM, Chen L, Bai B, Ma G, Ozcan A. A Novel Polarized Light Microscope for the[...]

Valle LF, Chu FI, Wang X, Erman A, Hernandez J, Kaoh E, Edgar N, Raldow AC, Wong DJ, Steinberg ML, Kishan AU, Chin RK, Hegde[...]

Venkatesh KK, Grobman WA, Huang X, Yee LM, Catov J, Simhan H, Haas DM, Mercer B, Reddy U, Silver RM, Levine LD, Chung J, Saade[...]